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Materials and Methods 
 
1. Recombinant over-expression of AbyU 
The gene encoding AbyU was amplified from Verrucosispora maris AB-18-032 genomic DNA 
and inserted into the plasmid pOPINF1 as described previously.2 This construct 
(abyU::pOPINF) encodes an N-terminally hexa-histidine tagged variant of AbyU. Cultures of 
E. coli BL21(DE3) cells harbouring abyU::pOPINF were grown in 1 L Luria-Bertani (LB) 
medium, supplemented with 100 μg/mL carbenicillin, at 37 °C with shaking, until the optical 
density of the cultures at 600 nm had reached 0.6. Protein expression was induced by the 
addition of IPTG to a final concentration of 1 mM. Cultures were grown for an additional 16 
hours with shaking at 20 °C, following which cells were harvested by centrifugation at 4,600 
g, supernatants removed, and remaining cell pellets flash frozen in liquid nitrogen and stored 
at -80 °C.  
 
2. Purification of AbyU  
Frozen cell pellets were thawed on ice and re-suspended in 35 mL of His-load buffer (50 mM 
Tris-HCl, 150 mM NaCl, 20 mM imidazole, pH 7.5). Cells were lysed using a Microfluidizer 
(Constant Systems, UK) and the resulting lysate clarified by centrifugation at 38,000 g. 
Following centrifugation the supernatant was decanted and loaded onto a 5 mL His-Trap 
chelating column preloaded with nickel (GE Healthcare Life Sciences). The column was 
washed with 10 column volumes of load buffer to remove non-specifically bound proteins. 
Hexa-histidine tagged AbyU was eluted using a linear gradient of 0 - 50% His-load to His-elute 
buffer (50 mM Tris-HCl, 150 mM NaCl, 1 M imidazole, pH 7.5) with fractionation throughout (1 
mL). The absorbance of the column eluent was monitored continuously at 280 nm and was 
used to guide the selection of candidate fractions containing recombinant AbyU. 10 μL 
samples were removed from candidate fractions and subjected to SDS-PAGE analysis to 
assess protein purity and quantity. Fractions found to contain AbyU were pooled and 
concentrated by ultrafiltration to a final volume of 5 mL. Concentrated protein samples were 
loaded onto a Superdex S75 gel filtration column (GE Healthcare) pre-equilibrated with size 
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exclusion chromatography (SEC) buffer comprising either, 20 mM Tris-HCl, 150 mM NaCl, pH 
7.5, for samples used for fluorescence analyses and in vitro enzyme assays; or 50 mM NaCl, 
20 mM NaPO4, pH 7.5, for samples used for circular dichroism analysis. Eluted fractions found 
to contain recombinant AbyU based on continuous monitoring of the absorbance of the column 
eluent at 280 nm followed by SDS-PAGE analysis, were pooled, concentrated to 10 mg/mL, 
flash frozen in liquid nitrogen and stored at -80 °C. SDS-PAGE and size exclusion 
chromatography analysis of AbyU was consistent with the protein being a dimeric, 
homogeneous species in solution. Protein samples used for all biophysical analyses were of 
at least 95% purity, as estimated from SDS-PAGE analysis (Figure S1).  
 
3. Circular dichroism spectroscopy 
Thermal and chemical denaturant induced circular dichroism (CD) unfolding studies of AbyU 
were conducted using a Jasco J-1500 spectrophotometer fitted with a Peltier temperature 
control unit. CD spectra were collected from 200 μL samples of purified AbyU (0.15 mg/mL) 
in assay buffer (50 mM NaCl, 20 mM NaPO4, pH 7.5), using a 1 mm path length spectroscopic 
grade cuvette (Hellma Analytics) pre-purged with nitrogen gas to cleanse any contaminants 
prior to sample analysis. For all experiments a High-Tension (HT) voltage of < 700 V was 
taken as the quality threshold for the CD signal.3 Thermal denaturation was achieved by 
heating samples from 25 °C to 95 °C in 5 °C increments, with continual monitoring of sample 
ellipticity from 190 - 260 nm throughout. Once the sample had reached 95 °C it was 
progressively cooled to 25 °C in 5 °C increments with sample ellipticity monitored as outlined 
above. For chemically induced unfolding CD experiments AbyU at 0.1 mg/mL was incubated 
for 30 minutes with denaturant (GuHCl; 0 - 6 M, 0.5 M increments) followed by assessment of 
sample ellipticity (190 - 260 nm). For both thermal and chemical unfolding experiments fraction 
folded values were calculated from mean sample ellipticity readings at 200 nm derived from 
three repeats of the same experiment. Errors bars reported are standard errors from the mean. 
Thermal unfolding profiles were fitted to a Boltzman sigmoid equation assuming a two-state 
model using GraphPad Prism. Chemical denaturation profiles were fitted to the Fersht 







4. Fluorescence unfolding studies  
For fluorescence unfolding studies 20 μL of AbyU (10 mg/mL) was mixed with 480 µL of SEC 
buffer (20 mM Tris-HCl, 150 mM NaCl, pH 7.5) supplemented with GuHCl (0 - 6 M, 0.5 M 
increments). Samples were incubated for 30 minutes at 25 °C prior to analysis. Fluorescence 
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was recorded using an Agilent Cary Eclipse Spectrophotometer with excitation at 295 nm and 
emission recorded between 305 – 405 nm. For refolding experiments AbyU (10 mg/ml) was 
incubated in SEC buffer supplemented with 6 M GuHCl for 15 minutes at 25 °C. Following 
incubation 20 µL aliquots of this protein sample was diluted into 480 µL of SEC buffer 
containing the desired concentration of GuHCl (0 - 6 M, 0.5 M increments). Samples were 
incubated for 15 minutes at 25 °C followed by analysis by fluorescence. All readings were 
taken using a 10 mm pathlength fluorescence quality quartz cuvette (Agilent technologies). 
For GuHCl unfolding experiments fraction folded values were calculated from fluorescence 
emission readings at 343 nm derived from three repeats of the same experiment. Errors bars 
reported are standard errors from the mean. For solvent induced unfolding studies 20 μL of 
AbyU (10 mg/mL) was diluted into 480 μL of SEC buffer supplemented with 0 - 100% v/v 
acetonitrile (MeCN), dimethyl sulphoxide (DMSO) or methanol (MeOH), in 10% increments. 
Samples were incubated for 30 minutes at 25 °C prior to analysis. Fluorescence was recorded 
as outlined above with excitation at 295 nm and emission recorded between 305 – 405 nm. 
All readings were normalized by subtraction of the solvent contributed fluorescence signal at 
each concentration.  
 
5. Kinetic unfolding studies  
Stopped-flow kinetic unfolding experiments were performed using an Applied Photophysics 
SX-17MV stopped-flow fluorimeter fitted with a 150 W Xenon-Mercury lamp, using a 
monochromatic slit width of 2 mm. Denaturant solutions comprised SEC buffer supplemented 
with GuHCl (4 - 8 M; 0.5 M increments). Purified AbyU (10 mg/mL) was rapidly mixed with 
buffered GuHCl solutions in the stopped-flow apparatus in a ratio of 1:25, giving a final protein 
concentration of 0.4 mg/mL. All samples were injected into a thermally regulated chamber 
maintained at 25 °C throughout. Excitation photons of wavelength 295 nm were used, and a 
monochromatic filter cut-off of 320 nm applied. All data was collected at 345 nm using a 
photomultiplier set to 300 V sensitivity. Instrument sample chambers were equilibrated with 
buffered denaturant or protein samples as appropriate prior to analysis. Data are presented 
as a mean average of four replicates, with the first data point excluded from curve fitting to 
remove a persistent mixing artefact. Data were fit to the sum of exponential functions using 
GraphPad Prism and the quality of each fit judged by residual plots (Figure S5). 
 
6. Substrate synthesis  
The AbyU substrate analogue 4 and Diels-Alder adduct 5 were synthesized as follows, using 








Dess-Martin periodinane (673 mg, 0.159 mmol) was added to a solution of tetronate 4 (50 mg, 
0.144 mmol) in CH2Cl2 (6 mL) and stirred at room temperature until TLC confirmed complete 
consumption of starting material to a less polar product (approx. 1 hour). The reaction was 
quenched with 5:1 mixture of sat. Na2S2O3(aq) and sat. NaHCO3(aq) and left to stir for 30 
minutes. The resulting mixture was separated and the aqueous layer extracted with CH2Cl2 (2 
× 6). The combined organic extracts were dried over MgSO4 and concentrated in vacuo. The 
crude material was purified by flash column chromatography (10-20% EtOAc/Hex) to give 4 
as a pale-yellow oil (28.5 mg, 57 %) as a 5:1 mixture of diastereomers. 1H NMR (400 MHz, 
CDCl3): (major) δH 7.30 – 7.21 (1H, overlapping m, 7-H), 6.58 (1H, dd, J 15.0, 10.5, 9-H), 6.30 
– 6.11 (3H, m, 6-H, 8-H and 10-H), 6.01 – 5.92 (1H, m, 11-H), 5.26 (1H, d, J 3.0, 6ʹHH), 5.21 
(1H, d, J 3.0, 6ʹ-HH), 4.11 (3H, s, OCH3), 3.68 – 3.60 (1H, m, 2-H), 2.86 – 2.77 (1H, m, 4-H), 
2.25 – 2.18 (1H, m, 3-HH), 1.83 (3H, d, J 7.0, 12-CH3), 1.39 – 1.17 (1H, m, 3-HH), 1.15 (3H, 
d, J 6.5, 2-CH3), 1.13 (3H, d, J 6.5, 4-CH3). 13C NMR (100 MHz, CDCl3): δC 203.4 (C-5), 200.7 
(C-1), 168.7 (C-5ʹ), 166.4 (C-2 ʹ), 148.9 (C-4ʹ), 143.4 (C-7), 142.3 (C-9), 135.5 (C-11), 131.5 
(C-10), 128.3 (C-8), 127.4 (C-6), 104.8 (C-1ʹ), 95.9 (C-6ʹ), 62.8 (OCH3), 42.4 (C-4), 42.2 (C-
4), 35.8 (C-3), 18.7 (C-12), 18.0 (2-CH3), 17.1 (4-CH3). 
All data is in accordance with the literature.5 
 
Diels Alder Adduct 
 
Tetronate 4 (10 mg, 0.0290 mmol) and hydroquinone (0.1 mg) was dissolved in CHCl3 (2 mL) 
and heated in a sealed tube at 75 °C for 2 days. The reaction mixture was cooled to room 
temperature and concentrated in vacuo. The crude material was purified by flash column 
chromatography (10-20% EtOAc/Hex) to give Diels-Alder adduct 5 as a yellow oil (6.4 mg, 
64%). 1H NMR (500 MHz, CDCl3): δH 6.47 (1H, dd, J 16.5, 6.0, 9-H), 6.25 (1H, d, J 16.5, 8-H), 




3.47 – 3.43 (1H, m, 10-H), 3.16 – 3.09 (1H, m, 4-H), 2.98 – 2.91 (1H, m, 6-H), 2.68 – 2.60 (1H, 
m, 13-H), 2.40 (1H, dd, J 14.5, 8.0, 14-HH), 1.87 (1H, ddd, J 15.5, 6.0, 4.0, 5-HH), 1.82 (1H, 
dd, J 14.5, 4.5, 14-HH), 1.21 (3H, d, J 7.0, 6-CH3), 1.19 (3H, d, J 7.0, 4-CH3), 1.17 – 1.13 (1H, 
overlapping m, 5-HH), 1.15 (3H, d, J 7.5, 13-CH3). 13C NMR (125 MHz, CDCl3): δC 204.3 (C-
7), 200.6 (C-3), 178.2 (C-16), 169.9 (C-1), 141.5 (C-9), 136.7 (C-12), 131.6 (C-8), 121.8 (C-
11), 107.0 (C-2), 86.1 (C-15), 61.7 (OCH3), 46.65 (C-4), 46.60 (C-6), 44.6 (C-10), 39.0 (C-5), 
36.6 (C-14), 29.3 (C-13) , 21.1 (13-CH3), 17.0 (6-CH3), 16.6 (4-CH3). 
All data is in accordance with the literature.5 
 
7. LC-MS assays  
The ability of AbyU to accept compound 4 as substrate for [4 + 2] cycloaddition was assessed 
in 20 μL assay mixes comprising 280 μM AbyU, 10 mM 4, 20 mM Tris-HCl, 150 mM NaCl, 
10% methanol, pH 7.5, as described previously.2 Assays were initiated by the addition of cold 
enzyme and incubated for 30 minutes at 25 °C, following which they were quenched by the 
addition of 30 μL of ice-cold acetonitrile and centrifuged at 11300 g to remove precipitated 
protein. Control experiments were performed as above but excluding enzyme, Assay 
components were extracted in 2 x 1 mL of ethyl acetate and dried under a stream of nitrogen 
gas. Resulting residues were re-suspended in 100 μL of acetonitrile, of which 50 μL was 
subjected to LC-MS analysis. Chromatographic separations were performed using a 
Phenomenex LUNA column (5 μ, C18, 100 Å, 4.6 x 250 mm), using a linear gradient of 10- 
90% acetonitrile/0.5% formic acid. Mass spectrometry was performed using a Waters ZQ 
Micromass spectrometer.  
 
8. Enzyme activity kinetic assays 
Reaction rates for the AbyU catalyzed conversion of 4 to 5 in the presence of increasing 
denaturant concentration were measured spectrophotometrically by monitoring the 
disappearance of 4 at 300 nm (ε300 nm = 18400 M-1cm-1). All assays were performed in reaction 
buffer comprising 20 mM Tris-HCl, 150 mM NaCl, pH 7.5, at 25 °C, using a 1 mm pathlength 
quartz cuvette (Hellma Analytics), with a 5 mM stock solution of 4 dissolved in acetonitrile. 
Assay mixes comprised AbyU (0.78 µM final concentration), diketone 4 (1 mM; ~x10 the Km 
for the AbyU catalyzed reaction2) and increasing concentrations of MeOH, MeCN, DMSO or 
GuHCl, dissolved in reaction buffer. Assays were initiated by the addition of diketone 4 
following a 10 min pre-incubation of enzyme with denaturant. Initial rates were calculated by 
monitoring the change in absorbance for at least 1 minute, following which rates for the non-
















Supplementary Figure 1. SDS-PAGE analysis of recombinant AbyU following purification by 
SEC. Each lane shows a 10 µL sample from a 1 mL fraction collected in sequence during 
purification (L-R). The theoretically calculated molecular mass of an AbyU monomer based on 






























Supplementary Figure 2. Equilibrium unfolding and refolding of AbyU. Unfolding (filled 















Supplementary Figure 3. HPLC analysis demonstrating the AbyU catalyzed conversion of 
diketone 4 to spirocyclic 5. (A) Synthetic standard of diketone 4. (B) 4 incubated with 280 μM 




















Supplementary Figure 4. (A) Mass spectrum of synthetic standard of diketone 4. (B) Mass 





































Supplementary Figure 5. Kinetics of AbyU unfolding. Representative unfolding time-course 
at 4.5 M GuHCl. Residual traces show that the data are best fit to two exponents. The 
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